Cover Image
市場調查報告書

預填充式、注射器的全球市場:趨勢、機會、預測

Global Prefilled Syringes Market: Trends, Opportunities and Forecasts 2016-2021

出版商 Azoth Analytics 商品編碼 355767
出版日期 內容資訊 英文 170 Pages
訂單完成後即時交付
價格
Back to Top
預填充式、注射器的全球市場:趨勢、機會、預測 Global Prefilled Syringes Market: Trends, Opportunities and Forecasts 2016-2021
出版日期: 2016年04月04日 內容資訊: 英文 170 Pages
簡介

本報告提供全球預填充式、注射器 (已填充藥劑之注射器) 的市場相關分析,整體市場規模的變化和預測,各材料、各容量、各用途詳細趨勢,各地區市場趨勢,主要的政策、法規環境,市場最新趨勢今後的方向性,最大企業的競爭力、業績比較,主要企業簡介等相關調查與考察。

第1章 分析方法

第2章 產品概要

第3章 摘要整理

第4章 全球預填充式、注射器市場分析

  • 市場規模與其預測
    • 以金額為主的成果值 (過去5年份)
    • 以金額為主的預測值 (今後6年份)
    • 以數量為準 (總計11年份)
    • 各材料 (今後6年份)
    • 各容量 (今後6年份)
    • 主要用途

第5章 北美的預填充式、注射器市場分析

第6章 南美的預填充式、注射器市場分析

第7章 亞太地區的預填充式、注射器市場分析

第8章 歐洲的預填充式、注射器市場分析

第9章 中東的預填充式、注射器市場分析

第10章 非洲的預填充式、注射器市場分析

第11章 產業結構

第12章 政策、規定概要

第13章 市場動態

  • 推動因素與課題
  • 市場趨勢
  • SWOT分析
  • 波特的五力分析

第14章 競爭環境

  • 預填充式、注射器的市場佔有率分析:各主要企業
  • 競爭力比較分析
    • 銷售額比較:前五名公司
    • EBITDA比較:前五名公司
    • EBIT比較:前五名公司
    • PBT (稅款除外前利益) 比較:前五名公司
    • PAT (稅款除外後利益) 比較:前五名公司
    • 流動比率比較:前五名公司
    • 報酬率比較:前五名公司
    • 負債、資本比率比較:前五名公司
  • 企業簡介

第15章 策略建議

圖表一覽

目錄

Executive Summary

Safer injection practices through advancement in technology combined with the growing demand for self-administration of drugs among the population is increasingly responsible for the market for Prefilled Syringes globally.

Market for prefilled syringes has been witnessing growth majorly due to the advancement in technology for self-administration of drugs for diseases such as deep vein thrombosis and autoimmune diseases. Increasing demand of vaccination has also significantly contributed towards the prefilled syringes market.

Market for prefilled syringes has been majorly in the European region due to the increasing research and development and higher adoption rate among the population driven by the increase in the disposable income and higher standard of living. However, over the years, North America has evolved and is now at par with European region driven by the increasing demand among the population. During the forecast period, emerging economies are expected to significantly drive the market where Asia Pacific is expected to witness highest growth among the regions.

According to Azoth Analytics research report, “Global Prefilled Syringes Market: Trends, Opportunities and Forecasts (2016-2021)” - (By Material - Glass and Plastic; By Filling Capabilities - Single Chamber and Dual/Multiple Chamber; By Major Applications; By Region-North America, Europe, APAC, Latin America, Africa, Middle East; By Country - USA, Canada, Brazil, Mexico, UK, Germany, India, China, UAE, Saudi Arabia, South Africa)” the market has higher presence of glass made prefilled syringes, although, plastic made prefilled syringes is expected to grow at exponentially faster rate.

Scope of the Report

“Global Prefilled Syringes Market: Trends, Opportunities and Forecasts (2016-2021)” analyses the following aspects of Global Prefilled Syringes Market:

  • Executive Summary-Market, Drivers & Challenges and Trends
  • Prefilled Syringes Market Size & Forecast
  • By Material-Glass and Plastic
  • By Filling Capabilities-Single Chamber and Dual/Multiple Chamber
  • By Region-North America, Europe, APAC, Latin America, Africa, Middle East
  • By Country-USA, Canada, Brazil, Mexico, UK, Germany, India, China, UAE, Saudi Arabia, South Africa
  • Porter's Five Force Analysis and SWOT Analysis
  • Market Dynamics
  • Company Analysis

Research Methodology

Historic market trend has been figured out by various paid databases which was further triangulated with inputs and insights from industry experts through primary research (marketing managers, physicians). Back-of-the-Envelope calculation for the market estimation has been made through proper understanding of the market as well as future business strategies of the companies involved in the market.

Table of Contents

1. Research Methodology

2. Product Overview

3. Executive Summary

4. Global Prefilled Syringes Market: An Analysis

  • 4.1. Global Prefilled Syringes Market Size & Forecast
    • 4.1.1. Global Prefilled Syringes Market - By Value (Historic 2011-15)
    • 4.1.2. Global Prefilled Syringes Market - By Value (Forecast 2016E-2021F)
    • 4.1.3. Global Prefilled Syringes Market -By Volume (2011-2021F)
    • 4.1.4. Global Prefilled Syringes Market -By Material (2016E-2021F)
    • 4.1.5. Global Prefilled Syringes Market -By Filling Capabilities (2016E-2021F)
    • 4.1.6. Global Prefilled Syringes Market -By Major Applications, 2016

5. North America Prefilled Syringes Market: An Analysis

  • 5.1. North America Prefilled Syringes Market Size & Forecast
    • 5.1.1. North America Prefilled Syringes Market -By Value (Historic 2011-15)
    • 5.1.2. North America Prefilled Syringes Market -By Value (Forecast 2016E-2021F)
    • 5.1.3. North America Prefilled Syringes Market - By Material (Estimated 2016E)
    • 5.1.4. North America Prefilled Syringes Market - By Region (2011-2021F)
    • 5.1.5. North America Prefilled Syringes Market -By Region (2011-2021F)

6. Latin America Prefilled Syringes Market: An Analysis

  • 6.1. Latin America Prefilled Syringes Market Size & Forecast
    • 6.1.1. Latin America Prefilled Syringes Market Size - By Value (Historic 2011-15)
    • 6.1.2. Latin America Prefilled Syringes Market Size - By Value (Forecast 2016E-2021F)
    • 6.1.3. Latin America Prefilled Syringes Market Size - By Material (Estimated 2016E)
    • 6.1.4. Latin America Prefilled Syringes Market Size - By Region (2011-2021F)
    • 6.1.5. Latin America Prefilled Syringes Market Size - By Region (2011-2021F)

7. APAC Prefilled Syringes Market: An Analysis

  • 7.1. APAC Prefilled Syringes Market Size & Forecast
    • 7.1.1. APAC Prefilled Syringes Market - By Value (Historic 2011-15)
    • 7.1.2. APAC Prefilled Syringes Market - By Value (Forecast 2016E-2021F)
    • 7.1.3. APAC Prefilled Syringes Market - By Material (Estimated 2016E)
    • 7.1.4. APAC Prefilled Syringes Market - By Region (2011-2021F)
    • 7.1.5. APAC Prefilled Syringes Market - By Region (2011-2021F)

8. Europe Prefilled Syringes Market: An Analysis

  • 8.1. Europe Prefilled Syringes Market Size & Forecast
    • 8.1.1. Europe Prefilled Syringes Market - By Value (Historic 2011-15)
    • 8.1.2. Europe Prefilled Syringes Market - By Value (Forecast 2016E-2021F)
    • 8.1.3. Europe Prefilled Syringes Market - By Material (Estimated 2016E)
    • 8.1.4. Europe Prefilled Syringes Market - By Region (2011-2021F)
    • 8.1.5. Europe Prefilled Syringes Market - By Region (2011-2021F)

9. Middle East Prefilled Syringes Market: An Analysis

  • 9.1. Middle East Prefilled Syringes Market Size & Forecast
    • 9.1.1. Middle East Prefilled Syringes Market - By Value (Historic 2011-15)
    • 9.1.2. Middle East Prefilled Syringes Market - By Value (Forecast 2016E-2021F)
    • 9.1.3. Middle East Prefilled Syringes Market - By Material (Estimated 2016E)
    • 9.1.4. Middle East Prefilled Syringes Market - By Region (2011-2021F)
    • 9.1.5. Middle East Prefilled Syringes Market - By Region (2011-2021F)

10. Africa Prefilled Syringes Market: An Analysis

  • 10.1. Africa Prefilled Syringes Market Size & Forecast
    • 10.1.1. Africa Prefilled Syringes Market: By Value (Historic 2011-15)
    • 10.1.2. Africa Prefilled Syringes Market: By Value (Forecast 2016E-2021F)
    • 10.1.3. Africa Prefilled Syringes Market: By Material (2011-2021F)
    • 10.1.4. Africa Prefilled Syringes Market: By Region (2011-2021F)

11. Industry Structure

12. Policy and Regulatory Overview

13. Market Dynamics

  • 13.1. Drivers and Challenges
  • 13.2. Trends
  • 13.3. SWOT Analysis
  • 13.4. Porter Five Forces Analysis

14. Competitive Landscape

  • 14.1. Pre-filled Syringes Market Share Analysis, By Key Players
  • 14.2. Competitive Benchmarking
    • 14.2.1. Sales Comparatives, Top 5 Companies
    • 14.2.2. EBITDA Comparatives, Top 5 Companies
    • 14.2.3. EBIT Comparatives, Top 5 Companies
    • 14.2.4. PBT Comparatives, Top 5 Companies
    • 14.2.5. PAT Comparatives, Top 5 Companies
    • 14.2.6. Current Ratio Comparatives, Top 5 Companies
    • 14.2.7. Profit Margin Ratio Comparatives, Top 5 Companies
    • 14.2.8. Debt-Equity Ratio Comparatives, Top 5 Companies
  • 14.3. Company Profiling
    • 14.3.1. Becton, Dickinson & Company
    • 14.3.2. Gerresheimer Group
    • 14.3.3. Nipro Corporation
    • 14.3.4. Schott AG
    • 14.3.5. Stevanato Group
    • 14.3.6. Unilife Corporation
    • 14.3.7. Vetter Pharma-Fertigung GmbH & Co.
    • 14.3.8. West Pharmaceutical Services, Inc.
    • 14.3.9.Baxter International, Inc.
    • 14.3.10. Ypsomed AG

15. Strategic Recommendations

List of Figures

  • Figure 1: Classification of Syringes on basis of Material
  • Figure 2: Classification of Syringes on basis of Needle Types
  • Figure 3: Classification of Syringes on basis of Filling Capabilities
  • Figure 4: Global Prefilled Syringes Market, 2011-2015 (USD Billion
  • Figure 5: Prevalence of various autoimmune diseases globally
  • Figure 6: Global Prefilled Syringes Market Size Forecast, 2016E-2021F (USD Billion
  • Figure 7: Global Prefilled Syringes Market Size, By Volume, 2011-2015F (USD Billion)
  • Figure 8: Global Prefilled Syringes Market Size, By Volume, 2016-2021F (USD Billion)
  • Figure 9: Global Prefilled Syringes Market Size, By Material, 2016E (USD Billion)
  • Figure 10: Global Prefilled Syringes Market Size, By Material, 2021F (USD Billion)
  • Figure 11: Global Prefilled Syringes Market Size, By Filling Capabilities, 2016E (USD Billion)
  • Figure 12: Global Prefilled Syringes Market Size, By Filling Capabilities, 2021F (USD Billion)
  • Figure 13: Global Prefilled Syringes Market Size, By Major Applications, 2016 (In Percentage)
  • Figure 14: North America Prefilled Syringes Market, 2011-2015 (USD Billion)
  • Figure 15: North America Prefilled Syringes Market Size, 2016E-2021F (USD Billion)
  • Figure 16: North America Prefilled Syringes Market Size, By Material, 2016E (USD Billion)
  • Figure 17: North America Prefilled Syringes Market Size, By Material, 2021F (USD Billion)
  • Figure 18: U.S.A. Prefilled Syringes Market , 2011-2015 (USD Billion)
  • Figure 19: Influenza vaccination among adults aged 18 and over in U.S.A. (in %)
  • Figure 20: U.S.A. Prefilled Syringes Market, 2016E-2021F (USD Billion)
  • Figure 21: Canada Prefilled Syringes Market , 2011-2015 (USD Billion)
  • Figure 22: Causes for Death in Canada(in %)
  • Figure 23: Canada Prefilled Syringes Market Size, 2016E-2021F (USD Billion)
  • Figure 24: Latin Americ Prefilled Syringes Market, 2011-2015 (USD Billion)
  • Figure 25: Latin America Prefilled Syringes Market, 2016E-2021F (USD Billion)
  • Figure 26: Latin America Prefilled Syringes Market Size, By Material, 2016E (USD Billion)
  • Figure 27: Latin America Prefilled Syringes Market Size, By Material, 2021F (USD Billion)
  • Figure 28: Brazil Prefilled Syringes Market, 2011-2015 (USD Billion)
  • Figure 29: Brazil Prefilled Syringes Market Size, 2016E-2021F (USD Billion)
  • Figure 30: Mexico Prefilled Syringes Market , 2011-2015 (USD Billion)
  • Figure 31: Mexico Prefilled Syringes Market Size, 2016E-2021F (USD Billion)
  • Figure 32: APAC Prefilled Syringes Market, 2011-2015 (USD Billion)
  • Figure 33: APAC Prefilled Syringes Market, 2016E-2021F (USD Billion)
  • Figure 34: APAC Prefilled Syringes Market Size, By Material, 2016E (USD Billion)
  • Figure 35: APAC Prefilled Syringes Market Size, By Material, 2021F (USD Billion)
  • Figure 36: India Prefilled Syringes Market, 2011-2015 (USD Billion)
  • Figure 37: India Prefilled Syringes Market Size, 2016E-2021F (USD Billion)
  • Figure 38: China Prefilled Syringes Market , 2011-2015 (USD Billion)
  • Figure 39: China Prefilled Syringes Market Size, 2016E-2021F (USD Billion)
  • Figure 40: Europe Prefilled Syringes Market, 2011-2015 (USD Billion)
  • Figure 41: Europe Prefilled Syringes Market, 2016E-2021F (USD Billion)
  • Figure 42: Europe Prefilled Syringes Market Size, By Material, 2016E (USD Billion)
  • Figure 43: Europe Prefilled Syringes Market Size, By Material, 2021F (USD Billion)
  • Figure 44: United Kingdom Prefilled Syringes Market , 2011-2015 (USD Billion)
  • Figure 45: United Kingdom Prefilled Syringes Market Size, 2016E-2021F (USD Billion)
  • Figure 46: Germany Prefilled Syringes Market , 2011-2015 (USD Billion)
  • Figure 47: Germany Prefilled Syringes Market Size, 2016E-2021F (USD Billion)
  • Figure 48: Middle East Prefilled Syringes Market, 2011-2015 (USD Billion)
  • Figure 49: Middle East Prefilled Syringes Market, 2016E-2021F (USD Billion)
  • Figure 50: Middle East Prefilled Syringes Market Size, By Material, 2016E (USD Billion)
  • Figure 51: Middle East Prefilled Syringes Market Size, By Material, 2021F (USD Billion)
  • Figure 52: UAE Prefilled Syringes Market , 2011-2015 (USD Billion)
  • Figure 53: UAE Prefilled Syringes Market, 2016E-2021F (USD Billion)
  • Figure 54: Saudi Arabia Prefilled Syringes Market , 2011-2015 (USD Million)
  • Figure 55: Saudi Arabia Prefilled Syringes Market, 2016E-2021F (USD Million)
  • Figure 56: Africa Prefilled Syringes Market, 2011-2015 (USD Million)
  • Figure 57: Africa Prefilled Syringes Market, 2016E-2021F (USD Million)
  • Figure 58: Africa Prefilled Syringes Market Size, By Material, 2016E (USD Million)
  • Figure 59: Africa Prefilled Syringes Market Size, By Material, 2021F (USD Million)
  • Figure 60: South Africa Prefilled Syringes Market, 2011-2015 (USD Million)
  • Figure 61: South Africa Prefilled Syringes Market Size, 2016E-2021F (USD Million)
  • Figure 62: Industry Structure
  • Figure 63: Market Share
  • Figure 64: Sales Comparatives of Top 5 Companies (2011-2015)
  • Figure 65: EBITDA Comparatives of Top 5 Companies (2011-2015)
  • Figure 66: EBIT Comparatives of Top 5 Companies (2011-2015)
  • Figure 67: PBT Comparatives of Top 5 Companies (2011-2015)
  • Figure 68: PAT Comparatives of Top 5 Companies (2011-2015)
  • Figure 69: Current Ratio Comparatives of Top 5 Companies (2011-2015)
  • Figure 70: Profit Margin Ratio Comparatives of Top 5 Companies (2011-2015)
  • Figure 71: Debt-Equity Ratio Comparatives of Top 5 Companies (2011-2015)
  • Figure 72: BD Revenue & Other Financials (USD Million) CY 2011-2015 (September Ended)
  • Figure 73: BD Percentage Revenue, By Business Segment (2015 )
  • Figure 74: BD Percentage Revenue, By Geography (2015)
  • Figure 75: BD Percentage Employees, By Geography (2015)
  • Figure 76: BD Percentage Revenue, By Business Division - Medical Segment (2015)
  • Figure 77: BD Percentage Revenue, By Business Division - Life Sciences Segment (2015)
  • Figure 78: Gerresheimer AG Revenue (USD Million) AY 2011-2015 (November Ended)
  • Figure 79: Gerresheimer AG Percentage Revenue, By Business Segment (2015)
  • Figure 80: Gerresheimer AG Percentage Revenue, By Geography (2015)
  • Figure 81: Gerresheimer AG Percentage Employee, By Business Segment (2015)
  • Figure 82: Gerresheimer AG Percentage Employee, By Geography (2015)
  • Figure 83: Gerresheimer AG Percentage Revenue, By Region of Origin (2015)
  • Figure 84: Nipro Corporation Revenue & Other Financials (USD Million) FY 2011-2015
  • Figure 85: Nipro Corporation Percentage Revenue, By Business Segment (2015)
  • Figure 86: Nipro Corporation Percentage Revenue, By Geography (2015)
  • Figure 87: Nipro Corporation Medical-Related Business Percentage, By Sales Composition Mix (2015)
  • Figure 88: Nipro Corporation Pharma-Related Business, By No. of Contract Manufacturing Products (2015)
  • Figure 89: Nipro Corporation Glass-Related Business, By Sales Composition Mix (2015)
  • Figure 90: Schott AG Revenue & Other Financials (USD Million) AY 2011-2015 (Sep' Ended)
  • Figure 91: Schott AG Percentage Revenue, By Geography (2015)
  • Figure 92: Schott AG Percentage Revenue, By Geography (2015)
  • Figure 93: Schott AG Percentage Employee Count, By Geography (2015)
  • Figure 94: Unilife Revenue & Other Financials (USD Million) CY 2011-2015 (June Ended)
  • Figure 95: Unilife Percentage Revenue, By Geography (2015)
  • Figure 96: West Pharmaceutical Revenue & Other Financials (USD Million) CY 2011-2014
  • Figure 97: West Pharmaceutical Percentage Revenue, By Business Segment (2015)
  • Figure 98: West Pharmaceutical Percentage Revenue, By Geography (2015)
  • Figure 99: West Pharmaceutical Delivery Systems Percentage Revenue, By Business Division (2015)
  • Figure 100: Baxter Revenue & Other Financials (USD Million) CY 2011-2015
  • Figure 101: Baxter Percentage Revenue, By Business Segment (2015)
  • Figure 102: Baxter Percentage Revenue, By Geography (2015)
  • Figure 103: Baxter Hospital Product Segment Revenue Percentage, By Business Division (2015)
  • Figure 104: psomed AG Revenue & Other Financials (USD Million) FY 2011-2015
  • Figure 105: Ypsomed AG Percentage Revenue, By Business Segment (2015)
  • Figure 106: Ypsomed AG Percentage Revenue, By Geography (2015)

List of Tables

  • Table1: Arthritis Prevalence in North America
  • Table 2: Estimated Prevalence of Rheumatoid Arthritis in Canada
  • Table 3: Per Capita Health Expenditure in Latin America(USD Billion)
  • Table 4: Health Indicators in Latin America(USD Billion)
  • Table 5: Immunization Rate in Brazil
  • Table 6: Vaccination among infants in Mexico (in %)
  • Table 7: Comparison of Vaccination Coverage in APAC to the Americas
  • Table 8: Vaccination among infants in China (in %)
  • Table 9: Hip replacement surgery, 2013 (or nearest year)
  • Table 10: Total knee replacement surgery, 2013 (or nearest year)
  • Table 11: Joint Procedures in Germany
  • Table 12: Vaccination Coverage in Germany
  • Table 13: Estimated Cases of Orthopaedic Disorders in Middle East
  • Table 14: Estimated Cases of Rheumatoid Arthritis in Middle East
  • Table 15: UAE Estimated Prevalence of Joint Disorders
  • Table 16: Vaccination Rate in UAE
  • Table 17: Vaccination Rate in Saudi Arabia
  • Table 18: South Africa Vaccination Rate
Back to Top